ALTI
AlTi Global, Inc.
ALTI lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ALTI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| N/A | |
| N/A |
ALTI's revenue is currently stable, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like ALTI.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ALTI PE Valuation
ALTI has no meaningful PE right now: it lost money over the past year.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ALTI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
ALTI has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ALTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.31 | — |
| Q3 2026 | -$0.57 | +$1.33 |
| Q2 2026 | -$1.25 | +$0.71 |
| Q1 2026 | -$1.27 | +$0.54 |
| Q4 2025 | -$1.32 | +$0.27 |
| Q3 2025 | -$1.90 | -$0.70 |
| Q2 2025 | -$1.96 | -$0.24 |
| Q1 2025 | -$1.81 | -$0.53 |
| Q4 2024 | -$1.59 | +$1.06 |
ALTI has the edge over IREN on earnings, with more consistent year-over-year improvement.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ALTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $57.9M | +1.2% |
| Q2 2026 | $58M | +9.2% |
| Q1 2026 | $73.1M | +26% |
| Q4 2025 | $88.3M | +65% |
| Q3 2025 | $57.2M | +7.3% |
| Q2 2025 | $53.1M | +7.4% |
| Q1 2025 | $58M | +14% |
| Q4 2024 | $53.3M | -42% |
ALTI's revenue has grown year over year for seven quarters in a row: $58M last quarter, up 1.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -10% | +40 points |
| Q2 2026 | -19% | +38 points |
| Q1 2026 | -15% | +8.7 points |
| Q4 2025 | -13% | +64 points |
| Q3 2025 | -50% | -20 points |
| Q2 2025 | -57% | -27 points |
| Q1 2025 | -23% | +5.6 points |
| Q4 2024 | -77% | -61 points |
ALTI has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ALTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.4M | +$9.8M |
| Q2 2026 | -$3.2M | +$16.8M |
| Q1 2026 | $5.3M | +$36.3M |
| Q4 2025 | $2.1M | +$4.1M |
| Q3 2025 | -$3.4M | +$6M |
| Q2 2025 | -$20M | +$11.3M |
| Q1 2025 | -$31M | -$15.3M |
| Q4 2024 | -$2M | -$931K |
ALTI has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ALTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.6% | +5.1M shares |
| 1 year | +14% | +13.9M shares |
| 3 years | +1.4% | +1.6M shares |
ALTI has 116M diluted shares, up 14% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $5.7M |
| Q1 2025 | $2.8M |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over ALTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ALTI Net Leverage
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ALTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.2 | Oversold |
| Stochastic | 5.5 | Oversold |
ALTI's weekly RSI is 27 (oversold) and its Stochastic is 6 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ALTI PE vs Financial Services Sector
ALTI has no meaningful PE right now: it lost money over the past year.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ALTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.55 | 34% below |
| 20 week MA | $3.21 | 48% below |
| 50 week MA | $3.66 | 54% below |
| 100 week MA | $3.72 | 55% below |
| 200 week MA | $5.06 | 67% below |
ALTI is in a downtrend: it's below all five of its weekly moving averages, and 67% below its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has the edge over ALTI on trend strength, trading above more of its moving averages.
ALTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $9.73 | $9.90 | +1.7% |
| 2022 | $9.90 | $10.0 | +1.3% |
| 2023 | $10.0 | $8.76 | -13% |
| 2024 | $8.76 | $4.39 | -50% |
| 2025 | $4.39 | $4.70 | +7.1% |
| 2026 YTD | $4.70 | $1.68 | -64% |
ALTI is down 64% so far in 2026, after finishing higher in three of the previous five years.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN has the edge over ALTI on returns for 2026, with the stronger performance.